Citigroup Inc Ishares Tr Genomics Immunology Transaction History

Citigroup Inc

$150 Billion
Q1 2024

A detailed history of Citigroup Inc transactions in Ishares Tr Genomics Immunology stock. As of the latest transaction made, Citigroup Inc holds 400 shares of IDNA stock, worth $9,248. This represents 0.0% of its overall portfolio holdings.

Number of Shares

400

Previous 400 -0.0%

Holding current value

$9,248

Previous $9,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2021 Nov 10, 2021	BUY	$48.15 - $55.47 $19,260 - $22,188	400 New	400 $20,000

Others Institutions Holding IDNA

# of Institutions

Shares Held

1.84M

Call Options Held

Put Options Held

Ubs Group Ag

324K
Shares

$7.49 Million
0.0% of portfolio
Wharton Business Group, LLC Malvern, PA

270K
Shares

$6.23 Million
0.31% of portfolio
Bank Of America Corp Charlotte, NC

266K
Shares

$6.15 Million
0.0% of portfolio
Morgan Stanley New York, NY

112K
Shares

$2.59 Million
0.0% of portfolio
Jane Street Group, LLC New York, NY

99.3K
Shares

$2.29 Million
0.0% of portfolio

View Full List

About ISHARES TR GENOMICS IMMUNOLOGY

Ticker IDNA
Sector ETFs
Industry ETFs

More about IDNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account